10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001558370-21-015489`
Period End Date	20210930
Filing Date	20211110
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	bpth-20210930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 34 Cash Flow Statement 36 Stockholders Equity 23

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$26.60M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$13.76M	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$1.27M	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$2.11M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$928.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.52M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$30.23M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$15.96M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.54M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	7.16M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	7.16M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.54M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.03M	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.08M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$854.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$798.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$231.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$222.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$225.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$288.00K	USD	Point-in-time
Total Assets	`Assets`	$16.48M	USD	Point-in-time
Total Assets	`Assets`	$30.68M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$100.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$417.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$975.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$657.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$94.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$88.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.16M	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$172.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$236.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.33M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.41M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 7,160 and 4,542 shares issued and outstanding, respectively	`CommonStockValue`	$5.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 7,160 and 4,542 shares issued and outstanding, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$102.88M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$82.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-67.22M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-73.55M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$15.07M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$13.19M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$29.75M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$21.09M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$16.01M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$29.35M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$16.48M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$30.68M	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$981.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.04M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.00M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$970.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.09M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.32M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.32M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$6.33M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.07M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.97M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.36M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-8.36M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.97M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.07M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-6.33M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$25.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$25.00K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.32M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.33M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.07M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.96	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.80	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.26	USD	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7,038.00	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3,692.00	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3,692.00	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6,578.00	shares	3 Qtrs

Cash Flow Statement 36 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.32M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.33M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.07M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$591.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$432.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	$63.00K	USD	3 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	$58.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$54.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$56.00K	USD	3 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$840.00K	USD	3 Qtrs
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$204.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$489.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$591.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$176.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.00K	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$70.00K	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$63.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.37M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.12M	USD	3 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$47.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-47.00K	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$15.85M	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$12.20M	USD	Point-in-time
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	$4.16M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.01M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-8.37M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$12.85M	USD	3 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.43M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.60M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.06M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.76M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.43M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.60M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.06M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.76M	USD	Point-in-time

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$15.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$13.19M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$29.75M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$21.09M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$16.01M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$29.35M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$1.40M	USD	1 Quarter
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$15.85M	USD	3 Qtrs
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$4.16M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$262.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$143.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$432.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$591.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.32M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.97M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.33M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.07M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$15.07M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$13.19M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$29.75M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$21.09M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$16.01M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$29.35M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.